Basong, Clientlie Ken S.
HRN: 19-84-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/21/2022
04/27/2022
IV
200
Q6h
Pneumonitis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes